Diplomat Pharmacy, Inc. (DPLO) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
4100 S. SAGINAW ST. FLINT, MI 48507 |
| State of Incorp. | MI |
| Fiscal Year End | December 31 |
| Industry (SIC) | 5912 - Drug Stores and Proprietary Stores (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 9/30/2019 MRQ | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 9 | 84 | 8 | 28 | 18 | |||
| Cash and cash equivalents | 9 | 84 | 8 | 28 | 18 | |||
| Receivables | 327 | 332 | 276 | 255 | 158 | |||
| Inventory, net of allowances, customer advances and progress billings | 211 | 207 | 215 | 166 | 111 | |||
| Inventory | 211 | 207 | 215 | 166 | 111 | |||
| Deferred tax assets | ✕ | 15 | 5 | 2 | ||||
| Other undisclosed current assets | 10 | 11 | 6 | 7 | 2 | |||
| Total current assets: | 556 | 634 | 520 | 461 | 291 | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 35 | 39 | 20 | 17 | 13 | |||
| Long-term investments and receivables | 0 | 5 | 4 | |||||
| Long-term investments | 0 | 5 | 4 | |||||
| Intangible assets, net (including goodwill) | 850 | 1,225 | 516 | 481 | 68 | |||
| Goodwill | 610 | 833 | 317 | 256 | 23 | |||
| Intangible assets, net (excluding goodwill) | 241 | 392 | 200 | 225 | 45 | |||
| Regulated entity, other noncurrent assets | 15 | |||||||
| Deferred costs | 5 | 1 | ||||||
| Other noncurrent assets | 5 | 6 | 1 | 0 | 1 | |||
| Other undisclosed noncurrent assets | 16 | 37 | 50 | 37 | 12 | |||
| Total noncurrent assets: | 920 | 1,306 | 588 | 545 | 99 | |||
| TOTAL ASSETS: | 1,476 | 1,940 | 1,108 | 1,006 | 390 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 342 | 444 | 339 | 313 | 209 | |||
| Employee-related liabilities | 13 | 10 | 6 | 6 | 2 | |||
| Accounts payable | 308 | 413 | 321 | 297 | 202 | |||
| Accrued liabilities | 21 | 21 | 12 | 11 | 4 | |||
| Debt | 12 | 12 | 8 | 6 | ||||
| Business combination, contingent consideration, liability | 5 | 8 | 53 | 6 | ||||
| Other undisclosed current liabilities | 200 | 188 | 39 | |||||
| Total current liabilities: | 559 | 651 | 385 | 372 | 215 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 438 | 521 | 100 | 111 | ||||
| Long-term debt, excluding current maturities | 438 | 521 | 100 | 111 | ||||
| Liabilities, other than long-term debt | 9 | 18 | 9 | 7 | 1 | |||
| Deferred tax liabilities, net | ✕ | 3 | 14 | 9 | 7 | 1 | ||
| Other liabilities | 0 | 0 | ||||||
| Business combination, contingent consideration, liability | 2 | 4 | ||||||
| Derivative instruments and hedges, liabilities | 4 | |||||||
| Other undisclosed noncurrent liabilities | 5 | 5 | ||||||
| Total noncurrent liabilities: | 453 | 539 | 109 | 118 | 6 | |||
| Total liabilities: | 1,011 | 1,191 | 494 | 490 | 221 | |||
| Equity | ||||||||
| Equity, attributable to parent, including: | 465 | 750 | 613 | 512 | 164 | |||
| Common stock | 629 | 619 | 504 | 452 | ||||
| Additional paid in capital | 51 | 38 | 33 | 29 | 10 | |||
| Accumulated other comprehensive loss | (4) | |||||||
| Retained earnings (accumulated deficit) | (211) | 92 | 76 | 31 | 5 | |||
| Other undisclosed equity, attributable to parent | 149 | |||||||
| Equity, attributable to noncontrolling interest | 0 | 4 | 5 | |||||
| Total equity: | 465 | 750 | 614 | 516 | 169 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,476 | 1,940 | 1,108 | 1,006 | 390 | |||
Income Statement (P&L) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 5,493 | 4,485 | 4,410 | 3,367 | 2,215 | ||
| Revenue, net | ✕ | ✕ | 4,485 | 4,410 | 3,367 | 2,215 | |
| Cost of revenue (Cost of Goods and Services Sold) | (5,117) | (4,137) | (4,086) | (3,103) | (2,087) | ||
| Other undisclosed gross profit | 12 | ||||||
| Gross profit: | 376 | 349 | 325 | 263 | 140 | ||
| Operating expenses | (643) | (330) | (278) | (217) | (136) | ||
| Other undisclosed operating income | 8 | ||||||
| Operating income (loss): | (267) | 19 | 47 | 46 | 13 | ||
| Nonoperating expense | (40) | (11) | (11) | (5) | (3) | ||
| Other nonoperating income | 2 | 0 | 0 | 0 | 1 | ||
| Interest and debt expense | (42) | (11) | (7) | (5) | (3) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (349) | (3) | 30 | 36 | 7 | ||
| Loss from equity method investments | (6) | ||||||
| Other undisclosed income from continuing operations before income taxes | 42 | 11 | 7 | 5 | 9 | ||
| Income (loss) from continuing operations before income taxes: | (307) | 8 | 36 | 41 | 9 | ||
| Income tax expense (benefit) | 5 | 7 | (11) | (16) | 5 | ||
| Income (loss) from continuing operations: | (302) | 15 | 25 | 25 | 14 | ||
| Income (loss) before gain (loss) on sale of properties: | (302) | 15 | 25 | 25 | 14 | ||
| Other undisclosed net loss | (9) | ||||||
| Net income (loss): | (302) | 15 | 25 | 25 | 5 | ||
| Net income attributable to noncontrolling interest | 0 | 3 | 1 | 0 | |||
| Net income (loss) attributable to parent: | (302) | 16 | 28 | 26 | 5 | ||
| Preferred stock dividends and other adjustments | 9 | ||||||
| Other undisclosed net loss available to common stockholders, basic | (10) | ||||||
| Net income (loss) available to common stockholders, diluted: | (302) | 16 | 28 | 26 | 4 | ||
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (302) | 15 | 25 | 25 | 5 | ||
| Comprehensive income (loss): | (302) | 15 | 25 | 25 | 5 | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 0 | 3 | 1 | 0 | |||
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (4) | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (307) | 16 | 28 | 26 | 5 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.